Search

Researchers have long known that outcomes for alcohol-associated liver disease (ALD) aren’t equal among all races and ethnicities in the U.S., but differences among these groups have been less clear.

New findings on mechanism for intestinal inflammation could offer new targets for treating ulcerative colitis, Crohn’s disease, and other conditions

Endocannabinoids, signaling molecules produced in the body that share features with chemicals found in marijuana, can shut down genes needed for some pathogenic intestinal bacteria to colonize, multiply, and cause disease, new research led by UT Southwestern scientists shows.

Physician assistant (PA) programs need to actively engage Black/African American students to help address issues of systemic racism, according to a new study.

Culinary medicine programs are emerging at medical schools to meet a critical need to improve nutrition education in an era of unprecedented diet-related health problems including obesity and cardiovascular disease.

Why do those with obesity so often develop high blood pressure? The answer could be as simple as loss of a sugar molecule.

UTSW study suggests combination therapy might help prostate cancer patients overcome resistance to current treatments.

Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide.

Adults with mild to moderate hearing loss who are considering buying hearing aids when they become available over the counter (OTC) later this month should first be examined by an audiologist and physician to determine if the devices will help them, UT Southwestern hearing specialists suggest.

As weight-loss drugs capture the public’s imagination, UTSW and its Nutrition Obesity Research Center are uniquely positioned to lead the way in discovery, education, and community outreach.